283 related articles for article (PubMed ID: 23893241)
1. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.
Shang Y; Zhang Z; Liu Z; Feng B; Ren G; Li K; Zhou L; Sun Y; Li M; Zhou J; An Y; Wu K; Nie Y; Fan D
Oncogene; 2014 Jun; 33(25):3267-76. PubMed ID: 23893241
[TBL] [Abstract][Full Text] [Related]
2. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.
Shang Y; Feng B; Zhou L; Ren G; Zhang Z; Fan X; Sun Y; Luo G; Liang J; Wu K; Nie Y; Fan D
Oncotarget; 2016 Jan; 7(1):538-49. PubMed ID: 26623719
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis.
Ba MC; Ba Z; Gong YF; Lin KP; Wu YB; Tu YN
Aging (Albany NY); 2021 Jul; 13(13):17285-17301. PubMed ID: 34226297
[TBL] [Abstract][Full Text] [Related]
4. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
5. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
6. DARPP-32 mediates multidrug resistance of gastric cancer through regulation of P-gp and ZNRD1.
Hong L; Wang J; Zhao Y; Han Z; Zhou X; Guo W; Zhang X; Jin H; Wu K; Ding J; Fan D
Cancer Invest; 2007 Dec; 25(8):699-705. PubMed ID: 18058465
[TBL] [Abstract][Full Text] [Related]
7. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.
An Y; Zhang Z; Shang Y; Jiang X; Dong J; Yu P; Nie Y; Zhao Q
Cell Death Dis; 2015 May; 6(5):e1766. PubMed ID: 25996293
[TBL] [Abstract][Full Text] [Related]
8. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein.
Shi Y; Zhang Y; Zhao Y; Hong L; Liu N; Jin X; Pan Y; Fan D
Cancer Biol Ther; 2004 Apr; 3(4):377-81. PubMed ID: 14726695
[TBL] [Abstract][Full Text] [Related]
10. Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters.
Wu Q; Yang Z; Xia L; Nie Y; Wu K; Shi Y; Fan D
Oncotarget; 2014 Nov; 5(22):11552-63. PubMed ID: 25344911
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NORAD/miR-202-5p regulates the drug resistance of A549/DDP to cisplatin by targeting P-gp.
Shen JG; Xu SN; Yin LG
Gen Physiol Biophys; 2020 Sep; 39(5):481-489. PubMed ID: 33084601
[TBL] [Abstract][Full Text] [Related]
13. Hsa-miR-34a-5p reverses multidrug resistance in gastric cancer cells by targeting the 3'-UTR of SIRT1 and inhibiting its expression.
Deng XJ; Zheng HL; Ke XQ; Deng M; Ma ZZ; Zhu Y; Cui YY
Cell Signal; 2021 Aug; 84():110016. PubMed ID: 33894312
[TBL] [Abstract][Full Text] [Related]
14. miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1.
Huang H; Tang J; Zhang L; Bu Y; Zhang X
Int J Oncol; 2018 Dec; 53(6):2769-2779. PubMed ID: 30320370
[TBL] [Abstract][Full Text] [Related]
15. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
[TBL] [Abstract][Full Text] [Related]
16. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
17. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
18. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
Wu DD; Li XS; Meng XN; Yan J; Zong ZH
Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361.
Wu X; Zheng Y; Han B; Dong X
Biomed Pharmacother; 2018 Mar; 99():832-838. PubMed ID: 29710482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]